Thus, therapy with NK cells modified to recognize antigens specifically expressed on the surface of cancer cells and to produce cytokines such as IL-2 and IL-15, which increase their survival capacity and proliferation and promote antitumor activity in vivo, provides another treatment option for bone metastasis [289]. The gene discussed is IL15; the disease is cancer.